Singapore markets close in 4 hours 20 minutes

United Therapeutics Corporation (UTHR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
276.44+1.25 (+0.45%)
At close: 04:00PM EDT
279.70 +3.26 (+1.18%)
After hours: 07:48PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
1,050,500
984,800
727,300
475,800
514,800
-
Depreciation & amortisation
54,900
53,200
51,300
49,900
49,900
-
Stock-based compensation
77,100
39,100
106,800
138,500
163,800
-
Change in working capital
-185,200
-97,800
-141,200
-174,200
63,100
-
Accounts receivable
-172,700
-58,500
-21,700
-41,300
-6,000
-
Inventory
-20,400
-13,600
-13,400
-7,500
10,300
-
Other working capital
752,400
747,600
663,700
477,400
696,400
-
Other non-cash items
-21,200
-4,900
52,500
65,900
-47,000
-
Net cash provided by operating activities
979,700
978,000
802,500
598,200
755,700
-
Cash flows from investing activities
Investments in property, plant and equipment
-227,300
-230,400
-138,800
-120,800
-59,300
-
Acquisitions, net
-
-89,200
0
0
0
-
Purchases of investments
-2,154,100
-2,514,300
-1,710,100
-1,895,300
-2,308,800
-
Sales/maturities of investments
2,734,700
2,137,300
1,033,900
1,529,200
1,627,200
-
Other investing activities
-
-23,000
3,500
-
-
-
Net cash used for investing activities
236,800
-719,600
-811,500
-486,900
-738,500
-
Cash flows from financing activities
Debt repayment
-200,000
-100,000
-800,000
0
-50,000
-
Common stock repurchased
-1,013,800
-13,800
-11,400
-10,800
-3,700
-
Other financing activities
-600
-2,700
-7,500
-
-1,700
-700
Net cash used provided by (used for) financing activities
-1,128,500
-11,900
75,400
44,800
-16,900
-
Net change in cash
88,000
246,500
66,400
156,100
300
-
Cash at beginning of period
1,163,500
961,200
894,800
738,700
738,400
-
Cash at end of period
1,251,500
1,207,700
961,200
894,800
738,700
-
Free cash flow
Operating cash flow
979,700
978,000
802,500
598,200
755,700
-
Capital expenditure
-227,300
-230,400
-138,800
-120,800
-59,300
-
Free cash flow
752,400
747,600
663,700
477,400
696,400
-